España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Humacyte
HUMA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Humacyte (HUMA) Forecast
News
Earnings
Humacyte (HUMA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Humacyte (NASDAQ:HUMA) Stock
Humacyte Stock (NASDAQ: HUMA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 21, 2024
Humacyte Announces The Publication Of Clinica...
Benzinga Newsdesk
D. Boral Capital Maintains Buy on Humacyte, M...
Benzinga Newsdesk
Monday, November 18, 2024
HC Wainwright & Co. Reiterates Buy on Humacyt...
Benzinga Newsdesk
Humacyte Presents Preclinical Results Of Smal...
Benzinga Newsdesk
Thursday, November 14, 2024
Humacyte Announces Pricing Of $15M Registered...
Benzinga Newsdesk
Wednesday, November 13, 2024
Peering Into Humacyte's Recent Short Interest
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Humacyt...
Benzinga Newsdesk
Monday, November 11, 2024
D. Boral Capital Maintains Buy on Humacyte, M...
Benzinga Newsdesk
Friday, November 08, 2024
Humacyte Q3 2024 GAAP EPS $(0.33) Misses $(0....
Benzinga Newsdesk
Thursday, November 07, 2024
Preview: Humacyte's Earnings
Benzinga Insights
Tuesday, November 05, 2024
HC Wainwright & Co. Maintains Buy on Humacyte...
Benzinga Newsdesk
Monday, October 28, 2024
EF Hutton Maintains Buy on Humacyte, Maintain...
Benzinga Newsdesk
Humacyte Announced The Presentation Of Result...
Benzinga Newsdesk
Monday, October 21, 2024
(HUMA) - Analyzing Humacyte's Short Interest
Benzinga Insights
Friday, October 18, 2024
Humacyte shares are trading higher. BTIG and ...
Benzinga Newsdesk
TD Cowen Reiterates Buy on Humacyte, Maintain...
Benzinga Newsdesk
BTIG Reiterates Buy on Humacyte, Maintains $1...
Benzinga Newsdesk
Thursday, October 17, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Humacyte shares are trading lower after an FD...
Benzinga Newsdesk
FDA Form 483 Highlights Key Compliance Issues...
Benzinga Newsdesk
Thursday, October 10, 2024
Benchmark Reiterates Buy on Humacyte, Maintai...
Benzinga Newsdesk
Tuesday, October 08, 2024
Humacyte To Present Late-Breaking Abstract Ac...
Benzinga Newsdesk
Friday, October 04, 2024
Humacyte Enters Securities Purchase Agreement...
Benzinga Newsdesk
Tuesday, October 01, 2024
EF Hutton Maintains Buy on Humacyte, Maintain...
Benzinga Newsdesk
Tuesday, September 24, 2024
Humacyte Option Alert: Oct 18 $7.5 Calls Swee...
Benzinga Newsdesk
Friday, September 20, 2024
Cantor Fitzgerald Reiterates Overweight on Hu...
Benzinga Newsdesk
Thursday, September 19, 2024
Humacyte Announces U.S. Patent Allowance For ...
Benzinga Newsdesk
Monday, September 09, 2024
EF Hutton Initiates Coverage On Humacyte with...
Benzinga Newsdesk
Thursday, September 05, 2024
How Is The Market Feeling About Humacyte?
Benzinga Insights
Benchmark Reiterates Buy on Humacyte, Maintai...
Benzinga Newsdesk
Tuesday, August 27, 2024
Humacyte Presents Long-Term Results Of ATEV I...
Benzinga Newsdesk
Monday, August 19, 2024
How Is The Market Feeling About Humacyte?
Benzinga Insights
Wednesday, August 14, 2024
Benchmark Reiterates Buy on Humacyte, Maintai...
Benzinga Newsdesk
Tuesday, August 13, 2024
Humacyte Q2 2024 GAAP EPS $(0.48) Misses $(0....
Benzinga Newsdesk
Monday, August 12, 2024
Unpacking the Latest Options Trading Trends in Humacyte
Benzinga Insights
Benchmark Reiterates Buy on Humacyte, Maintai...
Benzinga Newsdesk
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
Vandana Singh
Humacyte shares are trading lower after the c...
Benzinga Newsdesk
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, August 09, 2024
Humacyte shares are trading lower after the c...
Benzinga Newsdesk
Humacyte Says The FDA Will Require Additional...
Benzinga Newsdesk
Thursday, August 01, 2024
8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%
Hayden Buckfire
Wednesday, July 31, 2024
Humacyte shares are trading higher. The compa...
Benzinga Newsdesk
Humacyte Announced Topline Results From V007 ...
Benzinga Newsdesk
Tuesday, July 16, 2024
What's Going On With Huamacyte Shares Tuesday?
Dylan Berman
Monday, July 15, 2024
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
BTIG Maintains Buy on Humacyte, Raises Price ...
Benzinga Newsdesk
MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday
Avi Kapoor
(HUMA) - Analyzing Humacyte's Short Interest
Benzinga Insights
Humacyte shares are trading higher after the ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch